Public filings / INDV on Yahoo Finance (opens in a new tab)
INDV: insider buying, 13F holders, analyst moves
Indivior Pharmaceuticals Inc
A summary of public filings about Indivior Pharmaceuticals Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold INDV
Combined reported value $482.0M; 1 sold out since Q1 2026.
Holders among our 100 managers: 0 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Oaktree Capital Management | $251.4M | 4.73% | Trimmed |
| Madison Avenue Partners | $117.9M | 5.08% | Trimmed |
| Deerfield Company | $67.7M | 0.71% | Trimmed |
| Jeffrey L. Gendell | $45.0M | 0.41% | Unchanged |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.